Flunixin meglumine monoclonal antibody hybridoma cell strain YY and application thereof

A technology of flunixin meglumine and hybridoma cell lines, applied in biochemical equipment and methods, material inspection products, instruments, etc., can solve problems such as low sensitivity, difficulty in obtaining accurate results, lengthy separation and purification process, etc., and achieve The effect of good specificity and good detection sensitivity

Active Publication Date: 2017-06-20
JIANGNAN UNIV
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to effectively supervise and monitor the clinical use of flunixin meglumine in veterinary medicine, it is necessary to find a method with good specificity and high sensitivity. However, current detection methods such as thin-l

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Flunixin meglumine monoclonal antibody hybridoma cell strain YY and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1 Preparation of hybridoma cell line YY

[0019] (1) Preparation of complete antigen: Weigh 2.2 mg FM, 2.6 mg 1-ethylcarbodiimide hydrochloride, 1.6 mg N-hydroxysuccinimide, and dissolve with 400 μL anhydrous N,N-dimethylformaldehyde The amide was dissolved and stirred at room temperature for 6-8h (referred to as solution A). Take 10 mg of bovine serum albumin BSA (the molar ratio of FM to BSA is 30:1), and dissolve it with 4 mL of boric acid buffer solution (called solution B). At room temperature, add solution A to solution B dropwise, and react overnight at room temperature to obtain the conjugate FM-BSA mixture, and separate the complete antigen and unconjugated small molecule hapten by dialysis. Preparation of coated original FM-OVA: Weigh 1.6mg FM, 1.9mg 1-ethylcarbodiimide hydrochloride, 1.2mg N-hydroxysuccinimide, add 300μL anhydrous N,N-dimethyl Dissolve the formamide and stir at room temperature for 6-8 hours (referred to as liquid A). Weigh 5 mg...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a flunixin meglumine monoclonal antibody hybridoma cell strain YY and application thereof and belongs to the field of food safety immunoassay. The flunixin meglumine monoclonal antibody hybridoma cell strain YY disclosed by the invention is preserved in China General Microbiological Culture Collection Center (CGMCC for short) with a preservation number of CGMCC No.13096. The monoclonal antibody secreted by the cell strain has better specificity and detection sensitivity (an IC50 value is 0.24ng/mL) to flunixin meglumine, provides raw materials for immunoassay of flunixin meglumine residues in food and has an actual application value.

Description

technical field [0001] The invention relates to a flunixin meglumine monoclonal antibody hybridoma cell line YY and an application thereof, belonging to the field of food safety immunoassay. Background technique [0002] Flunixin meglumine (flunixin meglumine, FM) is a new type of non-steroidal animal-specific antipyretic and analgesic drugs, of which, flunixin (flunixin, molecular formula C 14 h 11 f 3 N 2 o 2 ) is a special structure of a class of non-steroidal anti-inflammatory analgesic antipyretic drugs, meglumine (meglumine, molecular formula C 7 h 17 NO 5 ) mainly acts as a stabilizer, and the two appear in a fixed ratio (1:1, that is, one molecule of flunicin combined with one molecule of meglumine), which is FM. In veterinary medicine, it is often used to relieve horses' visceral colic, pain caused by muscle and bone disorders, and anti-inflammation; to control acute inflammation caused by various diseases and infections in cattle, such as laminitis, arthriti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/20C07K16/44G01N33/577G01N33/94C12R1/91
CPCC07K16/44G01N33/577G01N33/9486
Inventor 胥传来林璐匡华徐丽广马伟刘丽强吴晓玲宋珊珊胡拥明
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap